Remission of severe aphthous stomatitis of celiac disease with etanercept.

Abstract

Celiac disease is a common autoimmune disease triggered by gluten-containing foods (wheat, barley and rye) in genetically predisposed individuals. We present a patient with celiac disease complicated by severe aphthous stomatitis resulting in impairing swallowing, chewing and speaking. This led to weight loss, psychosocial problems as well as inability to perform her work. A variety of topical and systemic medications used resulted in either no improvement or only partial alleviation of the patient's symptoms. After informed consent, etanercept was initiated and resulted in complete remission of aphthous stomatitis, decrease in arthralgia and fatigue and considerable improvement in her quality of life. The use of newer biological agents for selected and severe manifestations of celiac disease may lead to improved morbidity in these patients, but more studies are needed to determine long-term efficacy as well as safety of these drugs in the mucosal and/or systemic complications of this disease.

• Authors: Adey Hasan, Hiren Patel, Hana Saleh, George Youngberg, John Litchfield, Guha Krishnaswamy
• Journal: Clinical and molecular allergy : CMA (Clin Mol Allergy) Vol. 11 Issue 1 Pg. 6 (Dec 24 2013) ISSN: 1476-7961 [Print] England
• PMID: 24365222 (Publication Type: Case Reports)